Quote | Adagene Inc. (NASDAQ:ADAG)
Last: | $2.80 |
---|---|
Change Percent: | -1.96% |
Open: | $2.6 |
Close: | $2.80 |
High: | $2.8499 |
Low: | $2.6 |
Volume: | 3,971 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Adagene Inc. (NASDAQ:ADAG)
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Adagene Inc. (ADAG) is expected to report $-0.42 for Q4 2023
Message Board Posts | Adagene Inc. (NASDAQ:ADAG)
Subject | By | Source | When |
---|---|---|---|
good read | StockLogistics | investorshub | 04/25/2023 2:13:05 AM |
$ADAG what do you make of this data? | StockLogistics | investorshub | 04/24/2023 6:53:50 PM |
here we go bulls news is here | StockLogistics | investorshub | 04/23/2023 3:30:57 PM |
$ADAG Price trading | StockLogistics | investorshub | 04/23/2023 11:57:58 AM |
$ADAG must see | StockLogistics | investorshub | 04/23/2023 5:39:07 AM |
News, Short Squeeze, Breakout and More Instantly...
Adagene Inc. Company Name:
ADAG Stock Symbol:
NASDAQ Market:
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Adagene Inc. (ADAG) is expected to report $-0.42 for Q4 2023
- Global oncology expert brings deep insight in colorectal cancer and role of CTLA-4 therapy as a cornerstone for combination immunotherapy - SAN DIEGO and SUZHOU, China, March 07, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the dis...